Skip to main content

Military Health System

AFHSD’s GEIS collect data worldwide to support force protection

Image of Medical personnel scanning forehead of soldier with thermometer. Kuhina Talimalie, 735th Air Mobility Squadron, uses a no-touch thermometer on a U.S. Air Force airman to help mitigate the spread of COVID-19 among service members and the public. (Photo by Air Force Tech Sgt. Anthony Nelson Jr.)

Recommended Content:

Health Readiness & Combat Support | Public Health | Coronavirus & the MHS Response | Environmental Exposures | Global Health Engagement | Armed Forces Health Surveillance Division | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

Throughout 2020, the Armed Forces Health Surveillance Division and its Global Emerging Infections Surveillance branch continued to work with partners across the globe in their efforts to combat COVID-19 and protect military readiness. That work goes on even as vaccines for the disease have begun to be administered.

“We continue to fund worldwide respiratory pathogen surveillance studies and COVID-19-specific projects to understand the burden of disease and collect strains from infected cases across the globe,” said Navy Capt. Guillermo Pimentel, Global Emerging Infections Surveillance (GEIS) branch chief. These studies “allow the DOD to conduct advanced characterization of this novel coronavirus and support public health authorities of partner host nations.”

These efforts have allowed the Department of Defense to collect “critical information” for force health protection, and have allowed GEIS surveillance projects to reach approximately 80 countries, with its “principal strength being these partnerships with allies and demonstration of a field presence in key geographic locations of military relevance,” Pimentel added.

The data collected from surveillance studies are being used to “initiate, as well as to further adjust or modify, regional infectious disease protection guidance to maintain our forces ready to carry out their mission in each respective combatant command’s area of responsibility,” the GEIS chief said.

GEIS is also funding respiratory pathogen surveillance projects that provide data related to the burden of respiratory diseases to U.S and host nation militaries.

GEIS continues to fund COVID-19 genomic sequencing efforts from DOD service members and foreign nationals, Pimentel said. These sequencing efforts are at DOD labs in Cambodia, Thailand, Peru, and Kenya. By going outside the continental U.S., GEIS is better able to track the spread and impact in support of the combatant commands.

GEIS partners have sequenced more than 350 novel coronavirus isolates and have provided sequencing support to “multiple outbreaks in the Navy and Army,” he noted.

The Armed Forces Health Surveillance Division and its branches also continue to monitor influenza and other major health events and outbreaks that are of military relevance. In connection with academic partners and the Defense Threat Reduction Agency, the Integrated Biosurveillance Branch has a near real-time mapping application called the Health Surveillance Explorer that can be used to better respond to seasonal or pandemic influenza viruses, “estimate their impact on the readiness of the force, plan personnel requirements and implement interventions,” said IBB Chief Juan Ubiera.

GEIS’s military partners in its sequencing and tracking efforts are the Army (Walter Reed Army Institute of Research, U.S. Army Medical Research Institute of Infectious Diseases), Navy (Navy Medical Research Center, Naval Health Research Center) and Air Force (U.S. Air Force School of Aerospace Medicine).

One partner from USAFSAM, Dr. Anthony Fries, a bioinformaticist from the Air Force Research Laboratory’s 711th Human Performance Wing at Wright-Patterson, Ohio, said the AFRL continues to increase the sequencing of SARS-CoV-2 viruses “to assess what viral diversity is circulating in our service members.” Fries noted his lab has sequenced more than 800 patients with COVID-19.

“While the impact and optimism surrounding vaccines cannot be overstated…we are positioning our sequencing activities to see how this virus responds to a population that will soon have robust protection to it from these new vaccines,” Fries said. “From an evolutionary perspective, we’re hoping that this virus’s limited ability to diversify itself could restrict its ability to avoid our efforts to stop it with the new vaccines.”

Air Force Maj. (Dr.) Jameson Voss, chief, Air Force Medical Service Precision Medicine, Air Force Medical Readiness Agency, added: “We need to understand the genetic changes in the virus to ensure diagnostic, vaccine, and other countermeasures are still working.”

You also may be interested in...

COVID-19 Moderna Vaccine

Publication
8/17/2022

Moderna and mRNA vaccines are available. Moderna includes two doses, 28 days apart.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

COVID-19 Pfizer Vaccine

Publication
8/17/2022

Pfizer mRNA vaccines are available. Pfizer includes two doses, 21 days apart.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

COVID-19 Moderna and Pfizer Vaccines

Publication
8/17/2022

Moderna and Pfizer mRNA vaccines are available. Moderna includes two doses, 28 days apart. Pfizer includes two doses, 21 days apart. Remember to mark your calendar and schedule time for your second dose

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

Airborne Hazards and Open Burn Pit Registry DOD Health Care Provider Clinical Toolbox

Publication
7/21/2022

This toolbox contains background information on airborne hazards and the registry, guidance for conducting the medical evaluation, and resources for you to review and share with service members and other health care providers.

Recommended Content:

Airborne Hazards and Open Burn Pit Registry | Environmental Exposures

AHOBPR Health Care Provider Guide

Publication
7/21/2022

Learn how you, as a health care provider, can support service members participating in the Airborne Hazards and Open Burn Pit Registry.

Recommended Content:

Environmental Exposures | Airborne Hazards and Open Burn Pit Registry

Formulary Search Tool Buckslip: Color

Publication
1/27/2022

A color copy of buck slips on the TRICARE Formulary Search Tool. Educates beneficiaries what the search tool is and what information can be found. Includes a QR code, and features a link to esrx.com/tform. ESI and TRICARE logos are on the bottom right.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Pharmacy Operations Toolkit

Formulary Search Tool Buckslip: Black and White

Publication
1/27/2022

A set of three, black & white buck slips on the TRICARE Formulary Search Tool. Educates beneficiaries what the search tool is and what information can be found. Includes a QR code, and features a link to esrx.com/tform. ESI and TRICARE logos are on the bottom right.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Pharmacy Operations Toolkit

Airborne Hazards and Open Burn Pit Registry User Guide for Service Members

Publication
11/10/2021

The following guide is designed to help service members navigate the complete registry process. It describes the registry requirements; provides an in-depth, step-by-step guide for accessing, registering, and completing the Airborne Hazards and Open Burn Pit Registry questionnaire; and provides instructions for scheduling the optional, in-person medical exam.

Recommended Content:

Airborne Hazards and Open Burn Pit Registry | Environmental Exposures

Get to Know the Vaccines

Publication
9/17/2021

A graphic showing the types of vaccines, how they work, and safety monitoring of the vaccines. Includes the MHS and TRICARE logos on the bottom right, and includes graphics of scientists, doctors, and patients.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines

Get to know the COVID19 Vaccines

Publication
9/17/2021

Get to know the vaccines – they do not contain the live virus, they do not interact with our DNA, and have been tested rigorously.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines

Line Leader Presentation (Powerpoint)

Publication
8/4/2021

Leaders across the Department can leverage this briefing deck to discuss COVID-19 vaccines with their troops. Don't forget to reference speaker notes and to personalize the title slide!

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

Line Leader Presentation (PDF)

Publication
8/4/2021

This document is identical to the PowerPoint presentation for line leader reference and use.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

VAX Facts about Getting the COVID Vaccine at the Same Time as Others

Publication
6/9/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vax Facts

COVID-19 Vaccine Safety Monitoring

Publication
6/9/2021

The FDA and CDC continue to monitor the safety of COVID-19 vaccines. CDC has an independent group of experts that reviews all the safety data as it comes in and provides regular safety updates.

Recommended Content:

Get to Know the COVID-19 Vaccines | Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts | COVID-19 Vaccine Efforts

Get to Know the COVID-19 Vaccines (Combined)

Publication
6/9/2021

The Pfizer-BioNTech, Moderna, and Janssen (Johnson & Johnson) COVID-19 vaccines were developed to prevent infection from the virus that causes COVID-19. Learn about the vaccines, how they work and safety precautions.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | COVID-19 Vaccine Efforts
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 7
Refine your search
Last Updated: May 19, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery